<doc>
  <docmeta id="113s1277is">
    <bill congress="113" type="s" number="1277" version="is"/>
    <revision size="8206" annotations="0" status="complete" id="7" commit-time="2013-08-12T19:24:21Z" committer="mbohmer" doc="113s1277is/7.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<metadata>
<dublinCore>
<title>113 S1277 IS: Combating Prescription Drug Abuse Act</title>
<publisher>U.S. Senate</publisher>
<date>2013-07-10</date>
<format>text/xml</format>
<language>EN</language>
<rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 1277</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130710">July 10, 2013</action-date>
			<action-desc>
        <sponsor name-id="S223">Mrs. Boxer</sponsor> introduced
			 the following bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To establish a commission for the purpose of coordinating
		  efforts to reduce prescription drug abuse, and for other
		  purposes.</official-title>
	</form>
	<legis-body style="OLC">
		<section id="ID31184B49F2724544B4D65217C4705C1A" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Combating Prescription Drug Abuse
			 Act</short-title>
        </quote>.</text>
		</section>
    <section id="IDCA51A5031111442A88715C31794A9B28">
      <enum>2.</enum>
      <header>Commission</header>
			<subsection id="ID9094F1A9C08E470F98EFD4A6441E648B">
        <enum>(a)</enum>
        <header>Establishment</header>
        <text>There
			 is established the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Combating Prescription Drug Abuse Commission</cato:entity-ref> (referred to in
			 this Act as the <term>Commission</term>).</text>
			</subsection>
      <subsection id="IDE532E66A39BA47A4B3C6C106FE7AFC3E">
        <enum>(b)</enum>
        <header>Membership</header>
				<paragraph id="ID98E88B9CDDD64A25924F418989203619">
          <enum>(1)</enum>
          <header>Appointment</header>
          <text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> shall be composed of 30 members. Such members shall be appointed by
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0500">Comptroller General of the United States</cato:entity-ref>, in consultation with the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="id6F23FCB496E54B73A275683A0AF80CC1">
          <enum>(2)</enum>
          <header>Composition</header>
          <text>The
			 members appointed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Combating Prescription Drug Abuse Act/s:2/ss:b/p:1" proposed="true">paragraph (1)</cato:entity-ref> shall include an equitable balance of
			 individuals representing health care groups and law enforcement groups,
			 including—</text>
					<subparagraph id="idBC01C9C1848348F4887BD07E0CDE4687">
            <enum>(A)</enum>
            <text>a representative
			 of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement Administration</cato:entity-ref>;</text>
					</subparagraph>
          <subparagraph id="idC01E23B804BE4D40834648A0A629F2EF">
            <enum>(B)</enum>
            <text>a representative
			 of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>;</text>
					</subparagraph>
          <subparagraph id="id792C122FC050402A86FBB45DB333532F">
            <enum>(C)</enum>
            <text>a representative
			 of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1127">Office of National Drug Control Policy</cato:entity-ref>;</text>
					</subparagraph>
          <subparagraph id="idBAC42FE7F65B4E55AE7EB309FD162451">
            <enum>(D)</enum>
            <text>representatives
			 of patient, advocacy, and community-based groups;</text>
					</subparagraph>
          <subparagraph id="id458EC6505D264784B360ACF3980C8E58">
            <enum>(E)</enum>
            <text>representatives
			 of pharmacy, prescribers, hospitals, wholesalers, dispensers, manufacturers,
			 and other health care groups;</text>
					</subparagraph>
          <subparagraph id="id756988A00B1145C889323923DC4E541E">
            <enum>(F)</enum>
            <text>public policy
			 experts;</text>
					</subparagraph>
          <subparagraph id="idAD8C46FE5B63487E8D2533BD87E88C5E">
            <enum>(G)</enum>
            <text>representatives
			 of State attorneys general; and</text>
					</subparagraph>
          <subparagraph id="idFA3B75B2636A4A91B75C7F5EFBC7BA01">
            <enum>(H)</enum>
            <text>representatives
			 of law enforcement officials, including local law enforcement officials.</text>
					</subparagraph>
        </paragraph>
        <paragraph id="ID4F911B8DB59248E29F059E5131713461">
          <enum>(3)</enum>
          <header>Date of
			 appointment</header>
          <text>The appointments of the members of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref>
			 shall be made not later than 180 days after the date of enactment of this
			 Act.</text>
				</paragraph>
        <paragraph commented="no" id="id617E380AC3664DF48A326E7EB2EE9A6E">
          <enum>(4)</enum>
          <header>Co-Chairs</header>
          <text>The
			 representative of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement Administration</cato:entity-ref> and the representative of
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> shall serve as Co-Chairs of the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref>.</text>
				</paragraph>
        <paragraph commented="no" id="ID49FC1DF7437F4D65827F32F3B59A5C61">
          <enum>(5)</enum>
          <header>Period of
			 appointment; vacancies</header>
          <text>Members shall be appointed for the life of
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref>. Any vacancy in the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> shall not affect its powers, but
			 shall be filled in the same manner as the original appointment.</text>
				</paragraph>
      </subsection>
      <subsection commented="no" id="ID67F067576FFC463A842A5F7DA6A093C8">
        <enum>(c)</enum>
        <header>Meetings</header>
        <text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> shall meet at the call of the Co-Chairs. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> shall meet
			 for at least 2 public meetings, at which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> shall provide
			 opportunity for public input, comment, and suggestion.</text>
			</subsection>
      <subsection id="ID1BEFE42505154C978032F979F250D7A9">
        <enum>(d)</enum>
        <header>Duties of the
			 commission</header>
				<paragraph id="id21456A05C39C4C479EA2F001047AF481">
          <enum>(1)</enum>
          <header>In
			 general</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> shall—</text>
					<subparagraph id="idD64F3396F73247E097C539E20731BB2F">
            <enum>(A)</enum>
            <text>review and report
			 to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> on Federal initiatives with respect to efforts to prevent and
			 reduce prescription drug abuse;</text>
					</subparagraph>
          <subparagraph id="idA4D45A5A2AA74DDB9E503B4E761AC815">
            <enum>(B)</enum>
            <text>identify gaps and
			 opportunities with respect to ensuring the safe use of prescription drugs with
			 the potential for diversion and abuse; and</text>
					</subparagraph>
          <subparagraph id="id4162F114231A45F1A1A1D95671BEC52A">
            <enum>(C)</enum>
            <text>make
			 recommendations on specific ways to reduce diversion and abuse of prescription
			 drugs.</text>
					</subparagraph>
        </paragraph>
        <paragraph id="ID788980AB1AD147B0BAC1850A124EAF38">
          <enum>(2)</enum>
          <header>Report</header>
					<subparagraph id="id86BA157FB84044BB9DE08BD3AB134513">
            <enum>(A)</enum>
            <header>In
			 general</header>
            <text>Not later than 1 year after the date of enactment of this
			 Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> shall issue a report to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> that describes the efforts
			 of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> to prevent or reduce drug diversion and abuse to ensure that
			 patients continue to have access to medications.</text>
					</subparagraph>
          <subparagraph id="id2F533D1E00A74BFEABE9769A5E587345">
            <enum>(B)</enum>
            <header>Recommendations</header>
            <text>The
			 report described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Combating Prescription Drug Abuse Act/s:2/ss:d/p:2/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> shall include specific recommendations for
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement Administration</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>, and
			 other Federal and State agencies, as appropriate, and shall include the
			 following topics:</text>
						<clause id="idE5B823224AB647F790E1FBBA6E3F2BF5">
              <enum>(i)</enum>
              <text>Systems for
			 prescription drug monitoring, which shall include proposals to increase the use
			 and sustainability of prescription drug monitoring programs.</text>
						</clause>
            <clause id="id6C949BBE8FDC4CE3865938294AB8C91C">
              <enum>(ii)</enum>
              <text>Illegal Internet
			 prescription drug sites and <term>pill mills</term> that distribute
			 prescription drugs and fill prescriptions inappropriately.</text>
						</clause>
            <clause id="id1EEA6DC204C84F5C98097A3CFE8263B7">
              <enum>(iii)</enum>
              <text>Facilitating
			 proper disposal of prescription drugs, including public outreach and education
			 efforts with respect to such proper disposal.</text>
						</clause>
            <clause id="idFB822CF57E50492792DC642CC8594C42">
              <enum>(iv)</enum>
              <text>Identifying
			 active areas of prescription drug abuse.</text>
						</clause>
            <clause id="id49EFA167D85449808BF25E7982FB0274">
              <enum>(v)</enum>
              <text>Improving
			 collaboration among Federal agencies, especially the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement
			 Administration</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>.</text>
						</clause>
            <clause id="idBCBEC69035174DD98763CAB3F3D59D74">
              <enum>(vi)</enum>
              <text>Improving
			 collaboration between Federal agencies and relevant stakeholders, including the
			 groups represented on the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref>.</text>
						</clause>
            <clause id="id9B17556E0E444CE589F7263612C207DA">
              <enum>(vii)</enum>
              <text>The resource
			 needs for law enforcement.</text>
						</clause>
            <clause id="id0151ABD65B004F8E860ECED4211DCFC8">
              <enum>(viii)</enum>
              <text>Proposals to
			 improve the education of providers, patients, parents, and youth.</text>
						</clause>
            <clause id="idF400A48CE2334EE5B7FCD7A9EB813EA8">
              <enum>(ix)</enum>
              <text>Development of
			 abuse-resistant products.</text>
						</clause>
            <clause id="idD44ACC30555946B7BFDFEDB13EA47327">
              <enum>(x)</enum>
              <text>Recommendations
			 for reducing robberies, burglaries, and cargo theft.</text>
						</clause>
          </subparagraph>
        </paragraph>
      </subsection>
      <subsection commented="no" id="IDBF35816E08534CFC835DB84FCD77111A">
        <enum>(e)</enum>
        <header>Powers of the
			 Commission</header>
				<paragraph commented="no" id="ID78DA905C4EAE49B0AF74CB57183B6E1A">
          <enum>(1)</enum>
          <header>Hearings</header>
          <text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> may hold such hearings, sit and act at such times and places, take
			 such testimony, and receive such evidence as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> considers advisable
			 to carry out this section.</text>
				</paragraph>
        <paragraph commented="no" id="ID575D757C021D4B048F3625D80002BDAA">
          <enum>(2)</enum>
          <header>Information
			 from Federal agencies</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> may secure directly from any
			 Federal department or agency such information as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> considers
			 necessary to carry out this section. Upon the request of the Co-Chairs of the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref>, the head of such department or agency shall furnish such
			 information to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> in a timely manner.</text>
				</paragraph>
      </subsection>
      <subsection commented="no" id="idA136E53C768C43319DCCD795506CF13E">
        <enum>(f)</enum>
        <header>Confidentiality</header>
        <text>Information
			 obtained by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> from any Federal agency shall be exempt from
			 disclosure under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/552">
            <external-xref legal-doc="usc" parsable-cite="usc/5/552">section 552</external-xref> of title 5, United States Code</cato:entity-ref>. For purposes of
			 the preceding sentence, this subsection shall be considered a statute described
			 in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/552/b/3/B">subsection (b)(3)(B) of such section 552</cato:entity-ref>.</text>
			</subsection>
      <subsection commented="no" id="ID8E18677BEB06432BA5DE4BCFA806C638">
        <enum>(g)</enum>
        <header>Termination of
			 the commission</header>
        <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref>
			 shall terminate 2 years after the date on which the members are appointed under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Combating Prescription Drug Abuse Act/s:2/ss:b" proposed="true">subsection (b)</cato:entity-ref>.</text>
			</subsection>
      <subsection id="IDC0F48F3EB7C340C9BB05BD65FEBEFDFD">
        <enum>(h)</enum>
        <header>Authorization
			 of appropriations</header>
				<paragraph id="id4F10267457464411ABCE8FE5F689A577">
          <enum>(1)</enum>
          <header>In
			 general</header>
          <text>
            <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There is authorized to be appropriated <cato:funds-and-year amount="3000000" year="2014..2016">$3,000,000 for
			 fiscal years 2014 through 2016</cato:funds-and-year> to the <cato:entity-ref entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref> <cato:property name="purpose">to carry out <cato:entity-ref entity-type="act" value="Combating Prescription Drug Abuse Act/s:2" proposed="true">this
			 section</cato:entity-ref>
              </cato:property>.</cato:entity>
          </text>
				</paragraph>
        <paragraph id="id12A8BA1CDE0244A3AA6690E99F9B1ED5">
          <enum>(2)</enum>
          <header>Limitation on
			 use of funds</header>
          <text>No funds appropriated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Combating Prescription Drug Abuse Act/s:2/ss:h/p:1" proposed="true">paragraph (1)</cato:entity-ref> may be
			 used to carry out the recommendations of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Combating Prescription Drug Abuse Commission" proposed="true">Commission</cato:entity-ref>.</text>
				</paragraph>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>